Pages that link to "Q33591425"
Jump to navigation
Jump to search
The following pages link to Pulmonary surfactant phosphatidylglycerol inhibits respiratory syncytial virus-induced inflammation and infection (Q33591425):
Displaying 50 items.
- Adsorption of surfactant lipids by single-walled carbon nanotubes in mouse lung upon pharyngeal aspiration (Q23909704) (← links)
- Surfactant phospholipid metabolism (Q26826812) (← links)
- New surfactant with SP-B and C analogs gives survival benefit after inactivation in preterm lambs (Q27313764) (← links)
- Respiratory epithelial cells orchestrate pulmonary innate immunity (Q27687743) (← links)
- Resolvin D1 attenuates polyinosinic-polycytidylic acid-induced inflammatory signaling in human airway epithelial cells via TAK1 (Q28249812) (← links)
- Pulmonary surfactant pathophysiology: current models and open questions (Q28285439) (← links)
- Surfactant Lipids at the Host-Environment Interface. Metabolic Sensors, Suppressors, and Effectors of Inflammatory Lung Disease (Q28383936) (← links)
- Role for phospholipid acyl chains and cholesterol in pulmonary infections and inflammation (Q28391857) (← links)
- Surfactant and its role in the pathobiology of pulmonary infection (Q28395117) (← links)
- FTIR metabolomic fingerprint reveals different modes of action exerted by structural variants of N-alkyltropinium bromide surfactants on Escherichia coli and Listeria innocua cells (Q28543020) (← links)
- SP-B and SP-C containing new synthetic surfactant for treatment of extremely immature lamb lung (Q28727044) (← links)
- Nanodiscs as a therapeutic delivery agent: inhibition of respiratory syncytial virus infection in the lung (Q30431169) (← links)
- TLR4 Asp299Gly and Thr399Ile polymorphisms: no impact on human immune responsiveness to LPS or respiratory syncytial virus (Q33658939) (← links)
- Smoking reduces surfactant protein D and phospholipids in patients with and without chronic obstructive pulmonary disease (Q33727344) (← links)
- MALDI imaging MS of phospholipids in the mouse lung (Q33878265) (← links)
- MALDI imaging of lipid biochemistry in tissues by mass spectrometry (Q34028743) (← links)
- Review: Soluble innate immune pattern-recognition proteins for clearing dying cells and cellular components: implications on exacerbating or resolving inflammation. (Q34119510) (← links)
- CGI-58 knockdown in mice causes hepatic steatosis but prevents diet-induced obesity and glucose intolerance (Q34188075) (← links)
- Pulmonary Surfactant Phosphatidylglycerol Inhibits Mycoplasma pneumoniae-stimulated Eicosanoid Production from Human and Mouse Macrophages (Q34624136) (← links)
- SPLUNC1 promotes lung innate defense against Mycoplasma pneumoniae infection in mice (Q34839285) (← links)
- Phosphatidylinositol inhibits respiratory syncytial virus infection (Q35120910) (← links)
- Distinct effects of different phosphatidylglycerol species on mouse keratinocyte proliferation (Q35262169) (← links)
- Ion Mobility and Tandem Mass Spectrometry of Phosphatidylglycerol and Bis(monoacylglycerol)phosphate (BMP). (Q35379696) (← links)
- Anionic pulmonary surfactant lipid regulation of innate immunity (Q35648698) (← links)
- Effects of the New Generation Synthetic Reconstituted Surfactant CHF5633 on Pro- and Anti-Inflammatory Cytokine Expression in Native and LPS-Stimulated Adult CD14+ Monocytes (Q35899095) (← links)
- Phosphatidylglycerol suppresses influenza A virus infection (Q35987319) (← links)
- Inflammatory responses to respiratory syncytial virus (RSV) infection and the development of immunomodulatory pharmacotherapeutics (Q36174346) (← links)
- Genetic replacement of surfactant protein-C reduces respiratory syncytial virus induced lung injury (Q36687847) (← links)
- Molecular structures of fluid phase phosphatidylglycerol bilayers as determined by small angle neutron and X-ray scattering (Q36904617) (← links)
- Structural analogs of pulmonary surfactant phosphatidylglycerol inhibit toll-like receptor 2 and 4 signaling (Q36930183) (← links)
- Phosphatidylglycerol provides short-term prophylaxis against respiratory syncytial virus infection (Q37002647) (← links)
- Targeting RSV with vaccines and small molecule drugs (Q37328584) (← links)
- Lucinactant attenuates pulmonary inflammatory response, preserves lung structure, and improves physiologic outcomes in a preterm lamb model of RDS (Q37466166) (← links)
- Pattern recognition receptors and genetic risk for rsv infection: value for clinical decision‐making? (Q37801887) (← links)
- Pattern recognition receptors for respiratory syncytial virus infection and design of vaccines (Q38018768) (← links)
- Surfactant protein D as a biomarker for chronic obstructive pulmonary disease (Q38067753) (← links)
- Toll-like receptors in neonatal sepsis (Q38082543) (← links)
- Immunomodulatory properties of surfactant preparations (Q38083316) (← links)
- Host-Viral Interactions: Role of Pattern Recognition Receptors (PRRs) in Human Pneumovirus Infections (Q38163544) (← links)
- Lipidomic characterization and localization of phospholipids in the human lung. (Q38916413) (← links)
- Is phosphatidylglycerol essential for terrestrial life? (Q39013532) (← links)
- Lipidomes of lung cancer and tumour-free lung tissues reveal distinct molecular signatures for cancer differentiation, age, inflammation, and pulmonary emphysema (Q41317042) (← links)
- Secretory Phospholipase A2-Mediated Depletion of Phosphatidylglycerol in Early Acute Respiratory Distress Syndrome (Q42231767) (← links)
- Investigation of novel metabolites potentially involved in the pathogenesis of coronary heart disease using a UHPLC-QTOF/MS-based metabolomics approach (Q43757434) (← links)
- Report of the ‘Mechanisms of lung injury and immunomodulator interventions in influenza’ workshop, 21 March 2010, Ventura, California, USA* (Q46139825) (← links)
- Tandem mass spectrometry of novel ether-linked phospholipid analogs of anionic pulmonary surfactant phospholipids (Q46483679) (← links)
- Palmitic Acid: Physiological Role, Metabolism and Nutritional Implications. (Q46799280) (← links)
- Development and application of a comprehensive lipidomic analysis to investigate Tripterygium wilfordii-induced liver injury (Q51368921) (← links)
- Surfactant proteins A and D are related to severity of the disease, pathogenic bacteria and comorbidity in patients with chronic rhinosinusitis with and without nasal polyps (Q51608958) (← links)
- Phosphatidylglycerol Incorporates into Cardiolipin to Improve Mitochondrial Activity and Inhibits Inflammation (Q51737546) (← links)